These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17420965)

  • 1. [Ocular myasthenia gravis: diagnostic aspects and evolution].
    de Entrambasaguas M; López-Bernabé R; López-Alemany M
    Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients.
    Hong YH; Kwon SB; Kim BJ; Kim BJ; Kim SH; Kim JK; Park KS; Park KJ; Sung JJ; Sohn EH; Lee YB; Jeong D; Joo IS; Choi BO; Choi YC;
    J Neurol Sci; 2008 Oct; 273(1-2):10-4. PubMed ID: 18602121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
    Guan YZ; Cui LY; Liu MS; Niu JW
    Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single fiber electromyography in the diagnosis of ocular myasthenia gravis: report of 90 cases.
    Cui LY; Guan YZ; Wang H; Tang XF
    Chin Med J (Engl); 2004 Jun; 117(6):848-51. PubMed ID: 15198885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
    Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
    Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors].
    Deng Y; Zhang X
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1922-5. PubMed ID: 19953918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP
    Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular myasthenia: clinical course and strategies for treatment].
    Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
    Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SFEMG in ocular myasthenia gravis diagnosis.
    Padua L; Stalberg E; LoMonaco M; Evoli A; Batocchi A; Tonali P
    Clin Neurophysiol; 2000 Jul; 111(7):1203-7. PubMed ID: 10880794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mouse model of autoimmune ocular myasthenia gravis.
    Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular myasthenia gravis: the diagnostic yield of repetitive nerve stimulation and stimulated single fiber EMG of orbicularis oculi muscle and infrared reflection oculography.
    Oey PL; Wieneke GH; Hoogenraad TU; van Huffelen AC
    Muscle Nerve; 1993 Feb; 16(2):142-9. PubMed ID: 8429837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis.
    Elrod RD; Weinberg DA
    Ophthalmol Clin North Am; 2004 Sep; 17(3):275-309; v. PubMed ID: 15337189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
    Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
    J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S; Borchert M
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.